ArticleAIDS research and therapy2025
Prevalence of non-testing for HIV and associated factors among young women in Sub-Saharan africa: a multilevel analysis of DHS 2020-2024.
Article in AIDS research and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHIV testing services are crucial in preventing the spread of the virus and providing care for those infected. Despite the decline in the number of newly infected people, HIV/AIDS remains a major public health problem in Africa. Being aware of one's HIV status is linked to reduced risk and changes in behavior. Individuals who are newly diagnosed with HIV can quickly be linked to antiretroviral therapy (ART), as well as care and support service.
methodsData from the recent Demographic and Health Surveys were used for analysis. The study used a total of 82,361 young women. The determinants of non-testing were examined using a multilevel mixed-effects logistic regression model. Significant factors associated with HIV non-testing were declared significant at p-values < 0.05. The adjusted odds ratio and confidence interval were used to interpret the results. A model with the lowest deviance and highest logliklihood ratio was selected as the best-fit model.
resultsHIV non-testing prevalence among women in 12 Sub-Saharan Africa was 53.96% (95% CI: 53.61%, 54.30%). Women age (AOR = 1.88, 95% CI: 1.02, 1.38), educational level (AOR = 0.711, 95% CI: 0.673,0.751), marital status (AOR = 1.61, 95% CI: 1.5,1.74), media exposure (AOR = 1.08, 95% CI: 1.04,1.12), wealth index (AOR = 0.86, 95% CI: 0.82, 0.899), visited health facility (AOR = 0.41, 95% CI: 0.396, 0.424), Age at first sexual intercourse (AOR = 1.12, 95% CI: 1.001,1.25), risky sexual behavior (AOR = 1.34, 95% CI: 1.26,1.42), knowledge (AOR = 0.71, 95% CI: 0.684, 0.731), residence (AOR = 0.567, 95% CI: 0.542,0.592), distance from the health facility (AOR = 0.927, 95% CI: 0.893, 0.962), had higher odds of HIV non testing prevalence.
conclusionAccording to this study, the prevalence of HIV non-testing among young women in Sub-Saharan Africa is alarmingly high at 53.96%. This prevalence is determined by risky sexual activities, age, marital status and other factors. Targeted awareness campaigns, especially for those in disadvantaged circumstances, should be put into place to address this problem. Testing is promoted by stepping up community outreach and using media campaigns. Furthermore, expanding access to medical facilities and offering counseling services will motivate more young women to be checked, which will ultimately improve the region's health results. To achieve this, interventions such as mobile testing units, youth-friendly clinics, and school-based awareness campaigns should be prioritized to ensure effective engagement and support for young women.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.